ES483984A1 - Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina - Google Patents

Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina

Info

Publication number
ES483984A1
ES483984A1 ES483984A ES483984A ES483984A1 ES 483984 A1 ES483984 A1 ES 483984A1 ES 483984 A ES483984 A ES 483984A ES 483984 A ES483984 A ES 483984A ES 483984 A1 ES483984 A1 ES 483984A1
Authority
ES
Spain
Prior art keywords
medicaments
preparation
animal feedstuffs
feedstuffs containing
trihydroxypiperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES483984A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES483984A1 publication Critical patent/ES483984A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/98—Nitrogen atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Nuevos derivados de la 3, 4, 5-trihidroxipiperidina, a procedimientos para su obtención, así como a su empleo como medicamento, por ejemplo, como medio contra la prediabetes, gastritis, obstipación, infecciones del tractogastro-intestinal, meteorismo, flatulencia, caries, aterosclerosis, hipertensión y especialmente contra diabetes, hiperlipemia y adiposidad, así como en la alimentación de los animales para influenciar la proporción entre la carne y la gasa a favor de la parte de carne.
ES483984A 1978-09-09 1979-09-07 Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina Expired ES483984A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782839309 DE2839309A1 (de) 1978-09-09 1978-09-09 3,4,5-trihydroxypiperidin-derivate

Publications (1)

Publication Number Publication Date
ES483984A1 true ES483984A1 (es) 1980-05-16

Family

ID=6049044

Family Applications (1)

Application Number Title Priority Date Filing Date
ES483984A Expired ES483984A1 (es) 1978-09-09 1979-09-07 Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina

Country Status (11)

Country Link
US (1) US4278683A (es)
EP (1) EP0009633B1 (es)
JP (1) JPS5538388A (es)
AT (1) ATE1581T1 (es)
CA (1) CA1132571A (es)
DE (2) DE2839309A1 (es)
DK (1) DK155321C (es)
ES (1) ES483984A1 (es)
FI (1) FI72315C (es)
HU (1) HU180421B (es)
IL (1) IL58193A (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT7928324A0 (it) * 1979-12-21 1979-12-21 Chimosa Chimica Organica Spa Derivati piperidinici, stabilizzanti per polimeri sintetici.
DE3007078A1 (de) * 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3620645A1 (de) * 1985-12-20 1987-07-02 Bayer Ag 3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
US5302321A (en) * 1990-03-30 1994-04-12 Aquas Corporation Anticorrosive method of stream and condenser systems
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
DE19729640A1 (de) * 1996-08-17 1998-02-19 Ciba Geigy Ag Verfahren zur Herstellung von Nitrobenzamiden oder Aminobenzamiden
WO2010096764A1 (en) * 2009-02-23 2010-08-26 United Therapeutics Corporation Iminosugars and methods of treating viral diseases
CN102625660B (zh) * 2009-02-24 2015-03-11 联合治疗公司 亚氨基糖以及治疗沙粒病毒感染的方法
ES2524361T3 (es) 2009-06-12 2014-12-05 United Therapeutics Corporation Iminoazúcares para su uso en el tratamiento de enfermedades por bunyavirus y togavirus
CN102625801B (zh) * 2009-09-04 2015-09-09 联合治疗公司 治疗痘病毒感染的方法
KR20120081990A (ko) * 2009-09-04 2012-07-20 더 챈슬러 마스터즈 앤드 스칼라스 오브 더 유니버시티 오브 옥스포드 이미노당 및 필로바이러스 질환의 치료 방법
BR112012004676A2 (pt) * 2009-09-04 2019-09-24 United Therapeutics Corp método de tratar infecções orotomixovirais.
BR112018072298A2 (pt) 2016-05-02 2019-02-12 Florida State University Research Foundation, Inc. tratamento de infecções pelo vírus da zika usando inibidores da alfa-glicosidase
WO2021168483A2 (en) 2020-02-21 2021-08-26 Florida State University Research Foundation, Inc. Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.

Also Published As

Publication number Publication date
IL58193A0 (en) 1979-12-30
DK155321B (da) 1989-03-28
HU180421B (en) 1983-03-28
EP0009633A1 (de) 1980-04-16
EP0009633B1 (de) 1982-09-22
DE2963736D1 (en) 1982-11-04
JPS6241503B2 (es) 1987-09-03
DE2839309A1 (de) 1980-03-27
CA1132571A (en) 1982-09-28
JPS5538388A (en) 1980-03-17
DK375079A (da) 1980-03-10
US4278683A (en) 1981-07-14
FI72315B (fi) 1987-01-30
FI72315C (fi) 1987-05-11
FI792769A (fi) 1980-03-10
DK155321C (da) 1989-08-14
ATE1581T1 (de) 1982-10-15
IL58193A (en) 1983-05-15

Similar Documents

Publication Publication Date Title
ES483984A1 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
ES472838A1 (es) Procedimientos para la obtencion de derivados de 3,4,5-tri- hidropiperidina.
ES478047A1 (es) Procedimiento para la obtencion de acidos 4-piridon-3-car- boxilicos.
ES8609279A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,2,3-triazol.
MY110747A (en) Quinolone-and naphthyridonecarboxylic acid derivatives
ES8201549A1 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
ES8406448A1 (es) Procedimiento para la preparacion de fenilsulfoniloxibencimidazolcarbamatos sustituidos
AU6177880A (en) Preparation of new lysine-containing solid compositions for addition to animal feed
ES8106891A1 (es) Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas
ES8102147A1 (es) Procedimiento para la obtencion de derivados de sisomicina
ES8102096A1 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
ES476917A1 (es) Un procedimiento para la preparacion de derivados de acido -4-piridon-3-carboxilico.
ES8106003A1 (es) Procedimiento para la obtencion de acido fosfonohidroxiace- tico
ES8103112A1 (es) Procedimiento para la obtencion de pseudo-trisacaridos
ES8305783A1 (es) Procedimiento para la obtencion de derivados de aminociclitol saturados.
ES485697A1 (es) Procedimiento para la obtencion de derivados de 2-hidroxime-til-3,4,5-trihidroxi-piperidina.
ES483277A1 (es) Procedimiento para la obtencion de n-amino-3,4,5-tihidroxi- piperidinas
ES8308303A1 (es) Procedimiento para obtencion de derivados antibioticos de la cepa streptomyces spec. ws 116
ES8404677A1 (es) Procedimiento para la obtencion dederivados de 4h-1,4-benzotiazina.
ES8203843A1 (es) Procedimiento para la obtencion de amidas de acido 1,4-dihi-dropiridin-4-carboxilico
ES8203087A1 (es) Procedimiento para la obtencion de imidazolil-indeno-tiofe- nos
MN173A6 (en) Triethanolamine salt of 2,4-chlorophenoxycetic acid as biological stimulant

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401